Biorem Inc (BRM) AI Stock Analysis

• Market Cap: C$40.94M
• Dividend Yield: N/A
• Average Volume (3M): 32.44K
• Price to Earnings (P/E): 6.8
• Beta (1Y): 0.45
• Revenue Growth: -13.85%
• EPS Growth: -60.15%
• Country: CA
• Employees: 57
• Sector: General
• Sector Strength: N/A
• Industry: Industrial - Pollution & Treatment Controls
• EPS (TTM): 0.06
• Shares Outstanding: 16,117,027
• 10 Day Avg. Volume: 30,537
• 30 Day Avg. Volume: 32,440
• PEG Ratio: 0.44
• Price to Book (P/B): 4.53
• Price to Sales (P/S): 1.28
• P/FCF Ratio: 14.51
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.28
• Revenue Forecast (FY): C$45.20M

• Rating: 68 Neutral
• Price Target: C$3.00 ▲(13.21% Upside)
• Action: Downgraded Date: 02/03/26
• Date: Action: Downgraded 02/03/26

The score is driven mainly by solid financial health (low leverage and strong ROE) but is held back by weakening near-term fundamentals (TTM revenue decline, margin compression, and a sharp drop in free cash flow). Technically, the trend is positive versus key moving averages, though momentum indicators are mixed and RSI is elevated. Valuation is reasonable but not compelling relative to the recent operational slowdown.

Positive Factors

Low leverage / stronger balance sheet

Sustained low leverage and rising equity provide resilience for a project-driven industrial business. This reduces refinancing risk, supports bidding on larger engineered projects, and offers capacity to absorb revenue volatility or fund targeted investments over the next several quarters.

Negative Factors

TTM revenue decline and margin erosion

Falling revenue and compressed margins point to either weaker project demand or rising input/project costs. If persistent, this reduces free cash generation and return metrics, pressuring capital allocation and limiting the company's ability to scale or invest in new product/service initiatives over coming quarters.

Biorem Inc Business Overview & Revenue Model

Company Description

BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers bi...

Read more

BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers bi...

How the Company Makes Money

Biorem Inc generates revenue primarily through the sale of its proprietary bioremediation technologies and systems, which include biofilters and bioreactors. The company also earns money through consulting services that help clients design and imp...

Read more

Biorem Inc generates revenue primarily through the sale of its proprietary bioremediation technologies and systems, which include biofilters and bioreactors. The company also earns money through consulting services that help clients design and imp...

Biorem Inc Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Dec 2021	Mar 2021
Income Statement
Total Revenue	34.73M	37.42M	25.17M	28.86M	24.48M	24.38M
Gross Profit	8.42M	10.06M	7.02M	8.76M	6.24M	7.02M
EBITDA	3.56M	4.82M	3.45M	2.99M	2.68M	3.07M
Net Income	2.11M	3.04M	2.18M	1.61M	1.30M	2.09M
Balance Sheet
Total Assets	27.78M	28.51M	24.08M	20.73M	19.17M	21.95M
Cash, Cash Equivalents and Short-Term Investments	8.35M	5.21M	2.29M	3.78M	4.47M	8.87M
Total Debt	3.08M	3.56M	4.19M	4.75M	5.67M	828.17K
Total Liabilities	15.58M	17.89M	17.36M	16.21M	17.20M	8.43M
Stockholders Equity	12.20M	10.63M	6.72M	4.52M	1.96M	13.52M
Cash Flow
Free Cash Flow	2.23M	3.31M	-62.84K	1.24M	3.71M	2.99M
Operating Cash Flow	2.57M	3.69M	490.03K	1.44M	3.78M	3.34M
Investing Cash Flow	-344.80K	-372.00K	-552.87K	-203.29K	-75.98K	-342.40K
Financing Cash Flow	-610.04K	-572.04K	-1.33M	-951.80K	-7.56M	-199.74K

Biorem Inc Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 2.65
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:BRM, the sentiment is Neutral. The current price of 2.65 is above the 20-day moving average (MA) of 2.56, above the 50-day MA of 2.54, and above the 200-day MA of 2.30, indicating a neutral trend. The MACD of -0.03 indicates Positive momentum. The RSI at 46.80 is Neutral, neither overbought nor oversold. The STOCH value of 35.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:BRM.

Biorem Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BRM	68 Neutral	C$40.94M	6.78	18.99%	―	-13.85%	-60.15%
TMG	59 Neutral	C$23.90M	9.22	13.24%	―	-3.45%	-104.92%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
GRN	54 Neutral	C$35.90M	-34.71	-4.33%	―	-30.45%	―
DST	49 Neutral	C$6.10M	-14.31	24.47%	―	-27.49%	-32.97%
QST	44 Neutral	C$8.89M	-3.39	-7.46%	―	87.15%	47.74%
SHRC	42 Neutral	C$14.77M	-4.72	399.66%	―	14.18%	-29.19%

Biorem Inc Corporate Events